Upregulation of Trop-2 quantitatively stimulates human cancer growth
- PMID: 22349828
- DOI: 10.1038/onc.2012.36
Upregulation of Trop-2 quantitatively stimulates human cancer growth
Abstract
Trop-2 is a calcium signal transducer that is associated with transformed cell growth in experimental systems. However, its role in human cancer remains essentially unknown. In this study, we profiled Trop-2 expression in normal human tissues at the mRNA and protein levels. We then systematically compared Trop-2 mRNA and protein levels in tumours with their tissues of origin. We find that Trop-2 expression is invariably upregulated in tumours, regardless of baseline expression in normal tissues, which suggests a corresponding selective advantage. Thus, we investigated the outcome of Trop-2 upregulation on tumour growth. Overexpression of wild-type Trop-2 was shown to be necessary and sufficient to drive cancer growth in a widely invariant manner across cell type and species. Upregulation of Trop-2 was shown to quantitatively stimulate tumour growth, as proportional to expression levels in vivo, and tumour cell growth was abrogated by somatic knockdown of Trop-2 expression. On the other hand, we found no evidence of tumour-associated TROP2 mutations, nor of TROP2 induction of oncogenic transformation per se. Our data support a model where above-baseline expression of wild-type Trop-2 is a key driver of human cancer growth.
Similar articles
-
A bicistronic CYCLIN D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism in human cancer.Cancer Res. 2008 Oct 1;68(19):8113-21. doi: 10.1158/0008-5472.CAN-07-6135. Cancer Res. 2008. PMID: 18829570
-
The Trop-2 signalling network in cancer growth.Oncogene. 2013 Mar 21;32(12):1594-600. doi: 10.1038/onc.2012.151. Epub 2012 May 7. Oncogene. 2013. PMID: 22562244
-
[Expression and clinical significance of Trop-2 in human pancreatic cancer].Zhonghua Yi Xue Za Zhi. 2011 Jan 11;91(2):103-6. Zhonghua Yi Xue Za Zhi. 2011. PMID: 21418992 Chinese.
-
Trop2: from development to disease.Dev Dyn. 2015 Feb;244(2):99-109. doi: 10.1002/dvdy.24242. Dev Dyn. 2015. PMID: 25523132 Review.
-
Recent advances in trophoblast cell-surface antigen 2 targeted therapy for solid tumors.Drug Dev Res. 2021 Dec;82(8):1096-1110. doi: 10.1002/ddr.21870. Epub 2021 Aug 30. Drug Dev Res. 2021. PMID: 34462935 Review.
Cited by
-
Novel Anti-Trop2 Nanobodies Disrupt Receptor Dimerization and Inhibit Tumor Cell Growth.Pharmaceutics. 2024 Sep 27;16(10):1255. doi: 10.3390/pharmaceutics16101255. Pharmaceutics. 2024. PMID: 39458590 Free PMC article.
-
Trop-2, Na+/K+ ATPase, CD9, PKCα, cofilin assemble a membrane signaling super-complex that drives colorectal cancer growth and invasion.Oncogene. 2022 Mar;41(12):1795-1808. doi: 10.1038/s41388-022-02220-1. Epub 2022 Feb 7. Oncogene. 2022. PMID: 35132180
-
A non-mutated TROP2 fingerprint in cancer genetics.Front Oncol. 2023 Jun 29;13:1151090. doi: 10.3389/fonc.2023.1151090. eCollection 2023. Front Oncol. 2023. PMID: 37456256 Free PMC article.
-
Targeting Trop-2 in solid tumors: future prospects.Onco Targets Ther. 2019 Mar 1;12:1781-1790. doi: 10.2147/OTT.S162447. eCollection 2019. Onco Targets Ther. 2019. PMID: 30881031 Free PMC article. Review.
-
A unique four-hub protein cluster associates to glioblastoma progression.PLoS One. 2014 Jul 22;9(7):e103030. doi: 10.1371/journal.pone.0103030. eCollection 2014. PLoS One. 2014. PMID: 25050814 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous